Abiopharma

🔍 BELLEMARE ALAIN (Executive)

Company: DELTA AIR LINES, INC. (DAL)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Sold 20,621 shares of Common Stock at $72.751 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 120,025.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in column 4 is a weighted average price. The reported shares were sold in multiple transactions through a broker-dealer at prices ranging from $72.740 to $72.780 per share, inclusive. The Reporting Person undertakes to provide, upon request, details regarding the number of shares sold at each separate price to the Staff of the Securities and Exchange Commission, Delta Air Lines, Inc., or a security holder of Delta Air Lines, Inc.